NEET MDS Lessons
Pharmacology
TCI -Target Controlled Infusion
TCI is an infusion system which allows the anaesthetist to select the target blood concentration required for a particular effect and then to control depth of anaesthesia by adjusting the requested target concentration
Mechanism
Instead of setting ml/h or a dose rate (mg/kg/h), the pump can be programmed to target a required blood concentration.
• Effect site concentration targeting is now included for certain pharmacokinetic models.
• The pump will automatically calculate how much is needed as induction and maintenance to maintain that concentration.
Antiemetics
Antiemetic drugs are generally more effective in prophylaxis than treatment. Most antiemetic agents relieve nausea and vomiting by acting on the vomiting centre, dopamine receptors, chemoreceptors trigger zone (CTZ), cerebral cortex, vestibular apparatus, or a combination of these.
Drugs used in the treatment of nausea and vomiting belong to several different groups. These include:
1. Phenothiazines, such as chlorpromazine, act on CTZ and vomiting centre, block dopamine receptors, are effective in preventing or treating nausea and vomiting induced by drugs, radiation therapy, surgery and most other stimuli (e.g. pregnancy).
They are generally ineffective in motion sickness.
Droperidol had been used most often for sedation in endoscopy and surgery, usually in combination with opioids or benzodiazepines
2. Antihistamines such as promethazine and Dimenhyrinate are especially effective in prevention and treatment of motion.
3. Metoclopramide has both central and peripheral antiemetic effects. Centrally, it antagonizes the action of dopamine. Peripherally metoclopramide stimulates the release of acetylcholine, which in turn, increases the rate of gastric. It has similar indications to those of chlorpromazine.
4. Scopolamine, an anticholinergic drug, is very effective in reliving nausea & vomiting associated with motion sickness.
5. Ondansetron, a serotonin antagonist, is effective in controlling chemical-induced vomiting and nausea such those induced by anticancer drugs.
6. Benzodiazepines: The antiemetic potency of lorazepam and alprazolam is low. Their beneficial effects may be due to their sedative, anxiolytic, and amnesic properties
Etomidate -Intravenous Anesthetics
- A nonbarbiturate anesthetic used primarily to induce surgical anesthesia.
- It does not produce analgesia.
- Etomidate has minimal effect on the cardiovascular system and respiration during induction of anesthesia.
- Like the barbiturates, etomidate decreases cerebral blood flow, cerebral metabolic rate and intracranial pressure.
- No changes in hepatic, renal or hematologic function have been reported.
- Myoclonic muscle movements are relatively common.
- Postoperative nausea and vomiting are more common with etomidate than with barbiturates.
TRIMETHOPRIM
It is a diaminopyrimidine. It inhibits bacterial dihydrofolate reductase( DHFRase).
In combination with sulphamethoxzole it is called Co-trimoxazole.
Spectrum of action
S. Typhi. Serratia. Klebsiela and many sulphonamide resistant strains of Staph.aureus. Strep pyogens
Adverse effects
Megaloblastic anemia. i.e.. due to folate defeciency.
Contraindicated in pregnancy.
Diuretics if given with co-trimoxazole cause thrombocytopenia.
Uses
I. UTI. 2. RTI. 3. Typhoid. 5. Septicemias. 5. Whooping cough
Celecoxib
is a highly selective COX-2 inhibitor and primarily inhibits this isoform of cyclooxygenase, whereas traditional NSAIDs inhibit both COX-1 and COX-2. Celecoxib is approximately 10-20 times more selective for COX-2 inhibition over COX-1.
Being a sulphonamide can cause skin rash & hypersensitivity rxn., occasional oedema& HT.
Indication
Osteoarthritis ( 100‐200mg BID ) , rheumatoid arthritis, dysmenorrhea, acute gouty attacks, acute musculoskeletal pain.
SGLT-2 Inhibitors
canagliflozin
empagliflozin
Mechanism
glucose is reabsorbed in the proximal tubule of the nephron by the sodium-glucose cotransporter 2 (SGLT2)
SGLT2-inhibitors lower serum glucose by increasing urinary glucose excretion
the mechanism of action is independent of insulin secretion or action
Clinical use
type II DM
Pharmacokinetics
Pharmacokinetics is the way that the body deals with a drug - how that drug moves throughout the body, and how the body metabolizes and excretes it. The factors and processes involved in pharmacokinetics must be considered when choosing the most effective dose, route and schedule for a drug's use.
The four processes involved in pharmacokinetics are:
Absorption: The movement of a drug from its site of administration into the blood.
Several factors influence a drug's absorption:
- Rate of Dissolution: the faster a drug dissolves the faster it can be absorbed, and the faster the effects will begin.
- Surface Area: Larger surface area = faster absorption.
- Blood Flow: Greater blood flow at the site of drug administration = faster absorption.
- Lipid Solubility: High lipid solubility = faster absorption
- pH Partitioning: A drug that will ionize in the blood and not at the site of administration will absorb more quickly.
Distribution: The movement of drugs throughout the body.
Metabolism: (Biotransformation) The enzymatic alteration of drug structure.
Excretion: The removal of drugs from the body.
As a drug moves through the body, it must cross membranes. Some important factors to consider here then are:
Body's cells are surrounded by a bilayer of phospholipids (cell membrane).
There are three ways that a substance can cross cell membranes:
- Passing through channels and pores: only very small molecules can cross cell membranes this way.
- Transport Systems: Selective carriers that may or may not use ATP.
- Direct Penetration of the Cell Membrane: